tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
RESEARCH TOOLSreports

Gain Therapeutics (GANX) Financial Statements

Compare
425 Followers

Gain Therapeutics Financial Overview

Gain Therapeutics's market cap is currently $77.30M. The company's EPS TTM is $-0.11; its P/E ratio is -5.27; Gain Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 55.18K$ 132.64K$ 133.93K
Gross Profit$ -94.05K$ 0.00$ 55.18K$ -8.11M$ -7.03M
Operating Income$ -18.71M$ -20.35M$ -22.25M$ -17.78M$ -13.83M
EBITDA$ -18.71M$ -20.27M$ -22.17M$ -17.76M$ -13.82M
Net Income$ -20.16M$ -20.41M$ -22.27M$ -17.59M$ -13.89M
Balance Sheet
Cash & Short-Term Investments$ 20.84M$ 10.39M$ 16.79M$ 20.14M$ 36.88M
Total Assets$ 22.82M$ 12.12M$ 18.61M$ 24.10M$ 38.99M
Total Debt$ 331.11K$ 653.01K$ 1.03M$ 1.27M$ 1.61M
Net Debt$ -20.51M$ -9.73M$ -10.77M$ -6.04M$ -35.27M
Total Liabilities$ 4.25M$ 4.78M$ 6.03M$ 5.22M$ 4.17M
Stockholders' Equity$ 18.56M$ 7.34M$ 12.58M$ 18.88M$ 34.82M
Cash Flow
Free Cash Flow$ -18.47M$ -18.90M$ -18.88M$ -14.81M$ -12.46M
Operating Cash Flow$ -18.47M$ -18.87M$ -18.87M$ -14.69M$ -12.37M
Investing Cash Flow$ 0.00$ 4.98M$ 10.22M$ -14.77M$ -94.21K
Financing Cash Flow$ 28.45M$ 13.01M$ 12.64M$ -78.77K$ 41.77M
Currency in USD

Gain Therapeutics Earnings and Revenue History

Income Statement >

Gain Therapeutics Debt to Assets

Balance Sheet >

Gain Therapeutics Cash Flow

Cash Flow >

Gain Therapeutics Forecast EPS vs Actual EPS

Earnings >